Regeneron Pharmaceuticals Inc v. Novartis Vaccines Diagnostics Inc

Irena Royzman

Elizabeth J. Holland

Deanne M. Mazzochi

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Regeneron challenges Novartis's gene vector patent, arguing it is anticipated by its own prior patent due to a lack of written description for priority.

Regeneron Pharmaceuticals Inc

Novartis Vaccines Diagnostics Inc

Grifols Worldwide Operations Ltd

Last Docket Entry Date

Total Docket Entries

IPR2019-01086 | Regeneron Pharmaceuticals Inc v. Novartis Vaccines Diagnostics Inc | Ex Parte

Patent Trial and Appeal Board

Judge	Cases	Inst. Rate	FWD Inv. Rate
Christopher L Crumb Ly	1	0%	0%
Christopher L Crumbley	500+	62%	75%
Roberta Pollock	400+	70%	69%
Sheridan K Snedden	500+	65%	75%

Name	Ratings
Kramer Levin Naftalis & Frankel LLP	L4 A
Irena Royzman	-- -- --

Name	Ratings
Novartis Vaccines Diagnostics Inc	L5 E
Grifols Worldwide Operations Ltd	L2 C

Name	Ratings
Goodwin Procter LLP	L5 E
Elizabeth J. Holland	L5 D
Rakoczy Molino Mazzochi Siwik LLP	L1 D
Deanne M. Mazzochi	L4 A